Login Register Cart 0
Generic placeholder image

Endocrine, Metabolic & Immune Disorders - Drug Targets

Editor-in-Chief

ISSN (Print): 1871-5303
ISSN (Online): 2212-3873

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Impaired Myocardial MIF/AMPK Activation Aggravates Myocardial Ischemia Reperfusion Injury in High-Fat Diet-Induced Obesity

Author(s): Fanqing Meng, Dongliang Li , Bingfeng Song and Liang Li *

Volume 19, Issue 7, 2019

Page: [1046 - 1054] Pages: 9

DOI: 10.2174/1871530319666190326143254

Price: $65

Abstract

Background: Obese patients are more sensitive to myocardial ischemia, which has been linked with high mortality rates. The following study investigates the effects of impaired macrophage Migration Inhibitory Factor (MIF)/AMP-Activated Protein Kinase (AMPK) activation on increased susceptibility to myocardial ischemia/reperfusion (I/R) in high-fat diet-induced obesity.

Methods: Male C57BL/6J mice were fed with a normal diet (10% kcal as fat, lean group) or a high-fat diet (60kcal as fat, obese group) for 12 consecutive weeks. To detect the MIF expression and AMPK activation in response to I/R in isolated hearts from lean and obese mice, myocardial samples were collected from left ventricular areas at different time points. To determine whether MIF supplementation is protective against I/R injury, recombined MIF (10 ng/mL) was applied before ischemia. Myocardial infarct size was estimated by triphenyltetrazolium staining. Western blot was used to detect myocardial MIF expression, AMPK activation and membrane glucose transporter 4 (Glut4) expression.

Results: The expression of MIF was remarkably higher in obese group compared to lean group. Ischemia increased myocardial MIF expression and phosphorylation of AMPK in lean mice, whereas it had no significant effect on obese mice. Furthermore, administration of recombinant MIF increased ischemic AMPK activation and membrane Glut4 expression in both lean and obese mice, while it reduced the infarct size in lean mice only.

Conclusion: An impaired MIF/AMPK activation response and consequent reduced membrane Glut4 expression may play an important role in increasing myocardial susceptibility to I/R in obesity.

Keywords: Macrophage migration inhibitory factor, AMP-activated protein kinase, Obesity, Glucose transporter 4, myocardial ischemia/reperfusion injury, cardiovascular diseases.

« Previous Next »
Graphical Abstract

[1]
Kenchaiah, S.; Evans, J.C.; Levy, D.; Wilson, P.W.; Benjamin, E.J.; Larson, M.G.; Kannel, W.B.; Vasan, R.S.; Ramachandran, S.V. Obesity and the risk of heart failure. N. Engl. J. Med., 2002, 347(5), 305-313.
[http://dx.doi.org/10.1056/NEJMoa020245] [PMID: 12151467]
[2]
Dayawansa, N.H.; Gao, X.M.; White, D.A.; Dart, A.M.; Du, X.J. Role of MIF in myocardial ischaemia and infarction: insight from recent clinical and experimental findings. Clin. Sci. (Lond.), 2014, 127(3), 149-161.
[http://dx.doi.org/10.1042/CS20130828] [PMID: 24697297]
[3]
Stoppe, C.; Rex, S.; Goetzenich, A.; Kraemer, S.; Emontzpohl, C.; Soppert, J.; Averdunk, L.; Sun, Y.; Rossaint, R.; Lue, H.; Huang, C.; Song, Y.; Pantouris, G.; Lolis, E.; Leng, L.; Schulte, W.; Bucala, R.; Weber, C.; Bernhagen, J. Interaction of MIF family proteins in myocardial ischemia/reperfusion damage and their influence on clinical outcome of cardiac surgery patients. Antioxid. Redox Signal., 2015, 23(11), 865-879.
[http://dx.doi.org/10.1089/ars.2014.6243] [PMID: 26234719]
[4]
Stoppe, C.; Grieb, G.; Rossaint, R.; Simons, D.; Coburn, M.; Götzenich, A.; Strüssmann, T.; Pallua, N.; Bernhagen, J.; Rex, S. High postoperative blood levels of macrophage migration inhibitory factor are associated with less organ dysfunction in patients after cardiac surgery. Mol. Med., 2012, 18, 843-850.
[http://dx.doi.org/10.2119/molmed.2012.00071] [PMID: 22526918]
[5]
Koga, K.; Kenessey, A.; Powell, S.R.; Sison, C.P.; Miller, E.J.; Ojamaa, K. Macrophage migration inhibitory factor provides cardioprotection during ischemia/reperfusion by reducing oxidative stress. Antioxid. Redox Signal., 2011, 14(7), 1191-1202.
[http://dx.doi.org/10.1089/ars.2010.3163] [PMID: 20831446]
[6]
Miller, E.J.; Li, J.; Leng, L.; McDonald, C.; Atsumi, T.; Bucala, R.; Young, L.H. Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart. Nature, 2008, 451(7178), 578-582.
[http://dx.doi.org/10.1038/nature06504] [PMID: 18235500]
[7]
Russell, R.R., III; Bergeron, R.; Shulman, G.I.; Young, L.H. Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR. Am. J. Physiol., 1999, 277(2), H643-H649.
[PMID: 10444490]
[8]
Russell, R.R., III; Li, J.; Coven, D.L.; Pypaert, M.; Zechner, C.; Palmeri, M.; Giordano, F.J.; Mu, J.; Birnbaum, M.J.; Young, L.H. AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. J. Clin. Invest., 2004, 114(4), 495-503.
[http://dx.doi.org/10.1172/JCI19297] [PMID: 15314686]
[9]
Xing, Y.; Musi, N.; Fujii, N.; Zou, L.; Luptak, I.; Hirshman, M.F.; Goodyear, L.J.; Tian, R. Glucose metabolism and energy homeostasis in mouse hearts overexpressing dominant negative alpha2 subunit of AMP-activated protein kinase. J. Biol. Chem., 2003, 278(31), 28372-28377.
[http://dx.doi.org/10.1074/jbc.M303521200] [PMID: 12766162]
[10]
Dandona, P.; Aljada, A.; Ghanim, H.; Mohanty, P.; Tripathy, C.; Hofmeyer, D.; Chaudhuri, A. Increased plasma concentration of macrophage migration inhibitory factor (MIF) and MIF mRNA in mononuclear cells in the obese and the suppressive action of metformin. J. Clin. Endocrinol. Metab., 2004, 89(10), 5043-5047.
[http://dx.doi.org/10.1210/jc.2004-0436] [PMID: 15472203]
[11]
Herder, C.; Klopp, N.; Baumert, J.; Müller, M.; Khuseyinova, N.; Meisinger, C.; Martin, S.; Illig, T.; Koenig, W.; Thorand, B. Effect of macrophage migration inhibitory factor (MIF) gene variants and MIF serum concentrations on the risk of type 2 diabetes: results from the MONICA/KORA Augsburg Case-Cohort Study, 1984-2002. Diabetologia, 2008, 51(2), 276-284.
[http://dx.doi.org/10.1007/s00125-007-0800-3] [PMID: 17712545]
[12]
Palud, A.; Marciniak, C.; Montaigne, D.; Marechal, X.; Ballot, C.; Hassoun, S.M.; Decoster, B.; Neviere, R.; Lancel, S. Macrophage migration inhibitory factor inhibition is deleterious for high-fat diet-induced cardiac dysfunction. PLoS One, 2013, 8(3)e58718
[http://dx.doi.org/10.1371/journal.pone.0058718] [PMID: 23536817]
[13]
Xu, X.; Ren, J. Macrophage migration inhibitory factor (MIF) knockout preserves cardiac homeostasis through alleviating Akt-mediated myocardial autophagy suppression in high-fat diet-induced obesity. Int. J. Obes., 2015, 39(3), 387-396.
[http://dx.doi.org/10.1038/ijo.2014.174] [PMID: 25248618]
[14]
Afshin, A.; Forouzanfar, M.H.; Reitsma, M.B.; Sur, P.; Estep, K.; Lee, A.; Marczak, L.; Mokdad, A.H.; Moradi-Lakeh, M.; Naghavi, M.; Salama, J.S.; Vos, T.; Abate, K.H.; Abbafati, C.; Ahmed, M.B.; Al-Aly, Z.; Alkerwi, A.; Al-Raddadi, R.; Amare, A.T.; Amberbir, A.; Amegah, A.K.; Amini, E.; Amrock, S.M.; Anjana, R.M.; Ärnlöv, J.; Asayesh, H.; Banerjee, A.; Barac, A.; Baye, E.; Bennett, D.A.; Beyene, A.S.; Biadgilign, S.; Biryukov, S.; Bjertness, E.; Boneya, D.J.; Campos-Nonato, I.; Carrero, J.J.; Cecilio, P.; Cercy, K.; Ciobanu, L.G.; Cornaby, L.; Damtew, S.A.; Dandona, L.; Dandona, R.; Dharmaratne, S.D.; Duncan, B.B.; Eshrati, B.; Esteghamati, A.; Feigin, V.L.; Fernandes, J.C.; Fürst, T.; Gebrehiwot, T.T.; Gold, A.; Gona, P.N.; Goto, A.; Habtewold, T.D.; Hadush, K.T.; Hafezi-Nejad, N.; Hay, S.I.; Horino, M.; Islami, F.; Kamal, R.; Kasaeian, A.; Katikireddi, S.V.; Kengne, A.P.; Kesavachandran, C.N.; Khader, Y.S.; Khang, Y.H.; Khubchandani, J.; Kim, D.; Kim, Y.J.; Kinfu, Y.; Kosen, S.; Ku, T.; Defo, B.K.; Kumar, G.A.; Larson, H.J.; Leinsalu, M.; Liang, X.; Lim, S.S.; Liu, P.; Lopez, A.D.; Lozano, R.; Majeed, A.; Malekzadeh, R.; Malta, D.C.; Mazidi, M.; McAlinden, C.; McGarvey, S.T.; Mengistu, D.T.; Mensah, G.A.; Mensink, G.B.M.; Mezgebe, H.B.; Mirrakhimov, E.M.; Mueller, U.O.; Noubiap, J.J.; Obermeyer, C.M.; Ogbo, F.A.; Owolabi, M.O.; Patton, G.C.; Pourmalek, F.; Qorbani, M.; Rafay, A.; Rai, R.K.; Ranabhat, C.L.; Reinig, N.; Safiri, S.; Salomon, J.A.; Sanabria, J.R.; Santos, I.S.; Sartorius, B.; Sawhney, M.; Schmidhuber, J.; Schutte, A.E.; Schmidt, M.I.; Sepanlou, S.G.; Shamsizadeh, M.; Sheikhbahaei, S.; Shin, M.J.; Shiri, R.; Shiue, I.; Roba, H.S.; Silva, D.A.S.; Silverberg, J.I.; Singh, J.A.; Stranges, S.; Swaminathan, S.; Tabarés-Seisdedos, R.; Tadese, F.; Tedla, B.A.; Tegegne, B.S.; Terkawi, A.S.; Thakur, J.S.; Tonelli, M.; Topor-Madry, R.; Tyrovolas, S.; Ukwaja, K.N.; Uthman, O.A.; Vaezghasemi, M.; Vasankari, T.; Vlassov, V.V.; Vollset, S.E.; Weiderpass, E.; Werdecker, A.; Wesana, J.; Westerman, R.; Yano, Y.; Yonemoto, N.; Yonga, G.; Zaidi, Z.; Zenebe, Z.M.; Zipkin, B.; Murray, C.J.L. GBD 2015 Obesity Collaborators. Health effects of overweight and obesity in 195 countries over 25 years. N. Engl. J. Med., 2017, 377(1), 13-27.
[PMID: 28604169]
[15]
Isomaa, B.; Almgren, P.; Tuomi, T.; Forsén, B.; Lahti, K.; Nissén, M.; Taskinen, M.R.; Groop, L. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24(4), 683-689.
[http://dx.doi.org/10.2337/diacare.24.4.683] [PMID: 11315831]
[16]
Tabassum, F.; Batty, G.D. Are current UK National Institute for Health and Clinical Excellence (NICE) obesity risk guidelines useful? Cross-sectional associations with cardiovascular disease risk factors in a large, representative English population. PLoS One, 2013, 8(7)e67764
[http://dx.doi.org/10.1371/journal.pone.0067764] [PMID: 23844088]
[17]
Bandini, L.G.; Vu, D.; Must, A.; Cyr, H.; Goldberg, A.; Dietz, W.H. Comparison of high-calorie, low-nutrient-dense food consumption among obese and non-obese adolescents. Obes. Res., 1999, 7(5), 438-443.
[http://dx.doi.org/10.1002/j.1550-8528.1999.tb00431.x] [PMID: 10509600]
[18]
Thakker, G.D.; Frangogiannis, N.G.; Bujak, M.; Zymek, P.; Gaubatz, J.W.; Reddy, A.K.; Taffet, G.; Michael, L.H.; Entman, M.L.; Ballantyne, C.M. Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. Am. J. Physiol. Heart Circ. Physiol., 2006, 291(5), H2504-H2514.
[http://dx.doi.org/10.1152/ajpheart.00322.2006] [PMID: 16731644]
[19]
Song, T.; Lv, L.Y.; Xu, J.; Tian, Z.Y.; Cui, W.Y.; Wang, Q.S.; Qu, G.; Shi, X.M. Diet-induced obesity suppresses sevoflurane preconditioning against myocardial ischemia-reperfusion injury: role of AMP-activated protein kinase pathway. Exp. Biol. Med. (Maywood), 2011, 236(12), 1427-1436.
[http://dx.doi.org/10.1258/ebm.2011.011165] [PMID: 22075552]
[20]
Pohl, J.; Hendgen-Cotta, U.B.; Rammos, C.; Luedike, P.; Mull, E.; Stoppe, C.; Jülicher, K.; Lue, H.; Merx, M.W.; Kelm, M.; Bernhagen, J.; Rassaf, T. Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection. Thromb. Haemost., 2016, 115(1), 200-212.
[http://dx.doi.org/10.1160/TH15-05-0436] [PMID: 26310191]
[21]
Chan, W.; White, D.A.; Wang, X.Y.; Bai, R.F.; Liu, Y.; Yu, H.Y.; Zhang, Y.Y.; Fan, F.; Schneider, H.G.; Duffy, S.J.; Taylor, A.J.; Du, X.J.; Gao, W.; Gao, X.M.; Dart, A.M. Macrophage migration inhibitory factor for the early prediction of infarct size. J. Am. Heart Assoc., 2013, 2(5)e000226
[http://dx.doi.org/10.1161/JAHA.113.000226] [PMID: 24096574]
[22]
Fan, F.; Fang, L.; Moore, X.L.; Xie, X.; Du, X.J.; White, D.A.; O’Brien, J.; Thomson, H.; Wang, J.; Schneider, H.G.; Ellims, A.; Barber, T.W.; Dart, A.M. Plasma macrophage migration inhibitor factor is elevated in response to myocardial ischemia. J. Am. Heart Assoc., 2016, 5(7)e003128
[http://dx.doi.org/10.1161/JAHA.115.003128] [PMID: 27364992]
[23]
Pischon, T.; Girman, C.J.; Hotamisligil, G.S.; Rifai, N.; Hu, F.B.; Rimm, E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA, 2004, 291(14), 1730-1737.
[http://dx.doi.org/10.1001/jama.291.14.1730] [PMID: 15082700]
[24]
Zietz, B.; Herfarth, H.; Paul, G.; Ehling, A.; Müller-Ladner, U.; Schölmerich, J.; Schäffler, A. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett., 2003, 545(2-3), 103-104.
[http://dx.doi.org/10.1016/S0014-5793(03)00568-4] [PMID: 12804757]
[25]
Wang, Y.; Tao, L.; Yuan, Y.; Lau, W.B.; Li, R.; Lopez, B.L.; Christopher, T.A.; Tian, R.; Ma, X.L. Cardioprotective effect of adiponectin is partially mediated by its AMPK-independent antinitrative action. Am. J. Physiol. Endocrinol. Metab., 2009, 297(2), E384-E391.
[http://dx.doi.org/10.1152/ajpendo.90975.2008] [PMID: 19470831]
[26]
Gao, X.M.; Liu, Y.; White, D.; Su, Y.; Drew, B.G.; Bruce, C.R.; Kiriazis, H.; Xu, Q.; Jennings, N.; Bobik, A.; Febbraio, M.A.; Kingwell, B.A.; Bucala, R.; Fingerle-Rowson, G.; Dart, A.M.; Morand, E.F.; Du, X.J. Deletion of macrophage migration inhibitory factor protects the heart from severe ischemia-reperfusion injury: a predominant role of anti-inflammation. J. Mol. Cell. Cardiol., 2011, 50(6), 991-999.
[http://dx.doi.org/10.1016/j.yjmcc.2010.12.022] [PMID: 21215754]
[27]
Rossello, X.; Burke, N.; Stoppe, C.; Bernhagen, J.; Davidson, S.M.; Yellon, D.M. Exogenous administration of recombinant MIF at physiological concentrations failed to attenuate infarct size in a langendorff perfused isolated mouse heart model. Cardiovasc. Drugs Ther., 2016, 30(5), 445-453.
[http://dx.doi.org/10.1007/s10557-016-6673-2] [PMID: 27335054]
[28]
Qi, D.; Hu, X.; Wu, X.; Merk, M.; Leng, L.; Bucala, R.; Young, L.H. Cardiac macrophage migration inhibitory factor inhibits JNK pathway activation and injury during ischemia/reperfusion. J. Clin. Invest., 2009, 119(12), 3807-3816.
[http://dx.doi.org/10.1172/JCI39738] [PMID: 19920350]
[29]
Luedike, P.; Hendgen-Cotta, U.B.; Sobierajski, J.; Totzeck, M.; Reeh, M.; Dewor, M.; Lue, H.; Krisp, C.; Wolters, D.; Kelm, M.; Bernhagen, J.; Rassaf, T. Cardioprotection through S-nitros(yl)ation of macrophage migration inhibitory factor. Circulation, 2012, 125(15), 1880-1889.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.111.069104] [PMID: 22415145]
[30]
Stoppe, C.; Werker, T.; Rossaint, R.; Dollo, F.; Lue, H.; Wonisch, W.; Menon, A.; Goetzenich, A.; Bruells, C.S.; Coburn, M.; Kopp, R.; Bucala, R.; Bernhagen, J.; Rex, S. What is the significance of perioperative release of macrophage migration inhibitory factor in cardiac surgery? Antioxid. Redox Signal., 2013, 19(3), 231-239.
[http://dx.doi.org/10.1089/ars.2012.5015] [PMID: 23157710]
[31]
Wang, J.; Tong, C.; Yan, X.; Yeung, E.; Gandavadi, S.; Hare, A.A.; Du, X.; Chen, Y.; Xiong, H.; Ma, C.; Leng, L.; Young, L.H.; Jorgensen, W.L.; Li, J.; Bucala, R. Limiting cardiac ischemic injury by pharmacological augmentation of macrophage migration inhibitory factor-AMP-activated protein kinase signal transduction. Circulation, 2013, 128(3), 225-236.
[http://dx.doi.org/10.1161/CIRCULATIONAHA.112.000862] [PMID: 23753877]
[32]
Li, L.; Meng, F.; Li, N.; Zhang, L.; Wang, J.; Wang, H.; Li, D.; Zhang, X.; Dong, P.; Chen, Y. Exercise training prevents the attenuation of anesthetic pre-conditioning-mediated cardioprotection in diet-induced obese rats. Acta Anaesthesiol. Scand., 2015, 59(1), 85-97.
[http://dx.doi.org/10.1111/aas.12414] [PMID: 25312305]

Rights & Permissions Print Cite
Article Metrics
27
3
1
1
© 2024 Bentham Science Publishers | Privacy Policy